162 related articles for article (PubMed ID: 24715223)
1. The synthetic triterpenoid (CDDO-Im) inhibits STAT3, as well as IL-17, and improves DSS-induced colitis in mice.
Fitzpatrick LR; Stonesifer E; Small JS; Liby KT
Inflammopharmacology; 2014 Dec; 22(6):341-9. PubMed ID: 24715223
[TBL] [Abstract][Full Text] [Related]
2. Vidofludimus inhibits colonic interleukin-17 and improves hapten-induced colitis in rats by a unique dual mode of action.
Fitzpatrick LR; Small JS; Doblhofer R; Ammendola A
J Pharmacol Exp Ther; 2012 Sep; 342(3):850-60. PubMed ID: 22691298
[TBL] [Abstract][Full Text] [Related]
3. Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole.
Yates MS; Kwak MK; Egner PA; Groopman JD; Bodreddigari S; Sutter TR; Baumgartner KJ; Roebuck BD; Liby KT; Yore MM; Honda T; Gribble GW; Sporn MB; Kensler TW
Cancer Res; 2006 Feb; 66(4):2488-94. PubMed ID: 16489057
[TBL] [Abstract][Full Text] [Related]
4. The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo.
Place AE; Suh N; Williams CR; Risingsong R; Honda T; Honda Y; Gribble GW; Leesnitzer LM; Stimmel JB; Willson TM; Rosen E; Sporn MB
Clin Cancer Res; 2003 Jul; 9(7):2798-806. PubMed ID: 12855660
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of the Nrf2 activators tBHQ and CDDO-Im on the early events of T cell activation.
Zagorski JW; Turley AE; Freeborn RA; VanDenBerg KR; Dover HE; Kardell BR; Liby KT; Rockwell CE
Biochem Pharmacol; 2018 Jan; 147():67-76. PubMed ID: 29155145
[TBL] [Abstract][Full Text] [Related]
6. The synthetic triterpenoid CDDO-Imidazolide suppresses experimental liver metastasis.
Townson JL; Macdonald IC; Liby KT; Mackenzie L; Dales DW; Hedley BD; Foster PJ; Sporn MB; Chambers AF
Clin Exp Metastasis; 2011 Mar; 28(3):309-17. PubMed ID: 21234655
[TBL] [Abstract][Full Text] [Related]
7. Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide.
Shin S; Wakabayashi J; Yates MS; Wakabayashi N; Dolan PM; Aja S; Liby KT; Sporn MB; Yamamoto M; Kensler TW
Eur J Pharmacol; 2009 Oct; 620(1-3):138-44. PubMed ID: 19698707
[TBL] [Abstract][Full Text] [Related]
8. Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells.
Hyer ML; Croxton R; Krajewska M; Krajewski S; Kress CL; Lu M; Suh N; Sporn MB; Cryns VL; Zapata JM; Reed JC
Cancer Res; 2005 Jun; 65(11):4799-808. PubMed ID: 15930300
[TBL] [Abstract][Full Text] [Related]
9. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses.
Li YH; Xiao HT; Hu DD; Fatima S; Lin CY; Mu HX; Lee NP; Bian ZX
Pharmacol Res; 2016 Aug; 110():227-239. PubMed ID: 26969793
[TBL] [Abstract][Full Text] [Related]
10. The synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole blocks nuclear factor-kappaB activation through direct inhibition of IkappaB kinase beta.
Yore MM; Liby KT; Honda T; Gribble GW; Sporn MB
Mol Cancer Ther; 2006 Dec; 5(12):3232-9. PubMed ID: 17148759
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological induction of heme oxygenase-1 by a triterpenoid protects neurons against ischemic injury.
Zhang F; Wang S; Zhang M; Weng Z; Li P; Gan Y; Zhang L; Cao G; Gao Y; Leak RK; Sporn MB; Chen J
Stroke; 2012 May; 43(5):1390-7. PubMed ID: 22461332
[TBL] [Abstract][Full Text] [Related]
12. The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling.
Ling X; Konopleva M; Zeng Z; Ruvolo V; Stephens LC; Schober W; McQueen T; Dietrich M; Madden TL; Andreeff M
Cancer Res; 2007 May; 67(9):4210-8. PubMed ID: 17483332
[TBL] [Abstract][Full Text] [Related]
13. The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy.
Xu D; Chen L; Chen X; Wen Y; Yu C; Yao J; Wu H; Wang X; Xia Q; Kong X
Cell Death Dis; 2017 Aug; 8(8):e2983. PubMed ID: 28796242
[TBL] [Abstract][Full Text] [Related]
14. CDDO-Im ameliorates osteoarthritis and inhibits chondrocyte apoptosis in mice via enhancing Nrf2-dependent autophagy.
Dong J; Zhang KJ; Li GC; Chen XR; Lin JJ; Li JW; Lv ZY; Deng ZZ; Dai J; Cao W; Jiang Q
Acta Pharmacol Sin; 2022 Jul; 43(7):1793-1802. PubMed ID: 34754093
[TBL] [Abstract][Full Text] [Related]
15. Cytoprotection of human endothelial cells against oxidative stress by 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im): application of systems biology to understand the mechanism of action.
Wang X; Bynum JA; Stavchansky S; Bowman PD
Eur J Pharmacol; 2014 Jul; 734():122-31. PubMed ID: 24703885
[TBL] [Abstract][Full Text] [Related]
16. The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti-multiple myeloma (MM) activity and overcome bortezomib resistance.
Chauhan D; Li G; Podar K; Hideshima T; Shringarpure R; Catley L; Mitsiades C; Munshi N; Tai YT; Suh N; Gribble GW; Honda T; Schlossman R; Richardson P; Sporn MB; Anderson KC
Blood; 2004 Apr; 103(8):3158-66. PubMed ID: 15070698
[TBL] [Abstract][Full Text] [Related]
17. The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling.
Liby K; Hock T; Yore MM; Suh N; Place AE; Risingsong R; Williams CR; Royce DB; Honda T; Honda Y; Gribble GW; Hill-Kapturczak N; Agarwal A; Sporn MB
Cancer Res; 2005 Jun; 65(11):4789-98. PubMed ID: 15930299
[TBL] [Abstract][Full Text] [Related]
18. Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis.
Choi SH; Kim BG; Robinson J; Fink S; Yan M; Sporn MB; Markowitz SD; Letterio JJ
J Clin Invest; 2014 Jun; 124(6):2472-82. PubMed ID: 24837432
[TBL] [Abstract][Full Text] [Related]
19. Rho kinase Blockade Ameliorates DSS-Induced Ulcerative Colitis in Mice Through Dual Inhibition of the NF-κB and IL-6/STAT3 Pathways.
Wang Y; Duan X; Liu X; Liu Y; Fan H; Xu M; Chen Q; Tang Q
Inflammation; 2020 Jun; 43(3):857-867. PubMed ID: 31916050
[TBL] [Abstract][Full Text] [Related]
20. CDDO-Im exerts antidepressant-like effects via the Nrf2/ARE pathway in a rat model of post-stroke depression.
Hou X; Liu H; Ping Y; Zhang F; Zhi L; Jiang X; Zhang F; Song C; Zhang Z; Song J
Brain Res Bull; 2021 Aug; 173():74-81. PubMed ID: 33991607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
